Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen

Hepatology

Volumn 31, Issue 2, 2000, Pages 521-527

  Rahman, Fareed ^a   Dahmen, Anja ^a   Herzog Hauff, Sabine ^a   Böcher, Wulf O ^a   Galle, Peter R ^a   Löhr, Hanns E ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HLA A2 ANTIGEN; THYMIDINE;

ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMORAL IMMUNITY; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION;

EID: 0033967584     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510310237     Document Type: Article

References (14)

1. Rehermann B, Fowler P, Sidney J, Person J, Redeker A, Brown M, Moss B, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995;181:1047-1058.
2. Penna A, Chisari FV, Bertoletti A, Missale G, Fowler P, Giuberti T, Fiaccadori F, et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 1991;174:1565-1570.
3. Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, Vitiello A, et al. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 1993;150:4659-4671.
4. Maruyama T, McLachlan A, lino S, Koike K, Kurokawa K, Milich DR. The serology of chronic hepatitis B infection revisited. J Clin Invest 1993;91:2586-2595.
5. Seeff LB, Beebe GW, Hoofnagle JH, Norman JE, Buskell-Bales Z, Waggoner JG, Kaplowitz N, et al. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med 1987;316:965-970.
6. Moriyama T, Guilhot S, Klopchin K, Moss B, Pinkert CA, Palmiter RD, Brinster RL, et al. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 1990;248:361-364.
7. Löhr HF, Weber W, Schlaak J, Goergen B, Meyer zum Büschenfelde KH, Gerken G. Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants. HEPATOLOGY 1995;22:61-68.
8. Ferrari C, Penna A, Giuberti T, Tong MJ, Ribera E, Fiaccadori F, Chisari FV. Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol 1987;139:2050-2058.
9. Tsai SL, Chen PJ, Lai MY, Yang PM, Sung JL, Huang JH, Hwang LH, et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest 1992;89: 87-96.
10. Löhr HF, Krug S, Herr W, Weyer S, Schlaak J, Wōlfel T, Gerken G, et al. Quantitative and functional analysis of core specific T helper cell and CTL activities in acute and chronic hepatitis B. Liver 1998;18:413-424.
11. Löhr HF, Gerken G, Schlicht HJ, Meyer zum Büschenfelde KH, Fleischer B. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B. J Infect Dis 1993;168:1133-1139.
12. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Ann Rev Immunol 1995;13:29-60.
13. Sallberg M, Hughes J, Javadian A, Ronlov G, Hultgren C, Townsend K, Anderson CG, et al. Genetic immunization of chimpanzees chronically infected with the hepatitis B virus using a recombinant retroviral vector encoding the hepatitis B virus core antigen. Hum Gene Ther 1998;9:1719-1729.
14. Geissler M, Tokushige K, Wakita T, Zurawski VR, Wands JR. Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs Vaccine 1998;16:857-867.